Skip to main content
logo
ZYUS Life Sciences Corporation (TSXV:ZYUS)
Canada flag Canada · Delayed Price · Currency is CAD
0.5700
+0.0200 (3.64%)
At close: Mar 20, 2026

ZYUS Life Sciences Cash Flow Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-33.74-33.81-42.59-24.660.35-0.73
Depreciation & Amortization
2.892.963.114.05--
Stock-Based Compensation
0.210.410.270.11--
Other Adjustments
0.7618.8726.028.31-0.480.68
Change in Receivables
0.010.26-0.350.110.020.01
Changes in Inventories
0.40.32-0.020.45--
Changes in Accounts Payable
-0.860.7-5.122.34-0.220.02
Changes in Other Operating Activities
0.40.40.74-0.27--
Operating Cash Flow
-12.6-9.88-17.95-9.57-0.33-0.02
Capital Expenditures
-0.01-0.05-0.28-0.56--
Sale of Property, Plant & Equipment
0.01-----
Purchases of Investments
-1.87-0.06--0.97-0.12
Proceeds from Sale of Investments
----0.390.79
Payments for Business Acquisitions
--4.92-0.03--
Other Investing Activities
----00
Investing Cash Flow
1.891.834.58-0.59-0.580.67
Short-Term Debt Issued
0.40.70.351.04--
Short-Term Debt Repaid
-0.1-0.6-1.09-0.1--
Net Short-Term Debt Issued (Repaid)
0.30.1-0.740.94--
Long-Term Debt Issued
6.7552.452.05--
Long-Term Debt Repaid
-0.24-2-2.55---
Net Long-Term Debt Issued (Repaid)
7.393-0.12.05--
Issuance of Common Stock
1.643.3118.446.88--
Net Common Stock Issued (Repurchased)
1.643.3118.446.88--
Other Financing Activities
-0.15-0.44-0.46-0.24--
Financing Cash Flow
10.735.9717.149.63--
Net Cash Flow
0.02-2.083.77-0.54-0.910.65
Free Cash Flow
-12.61-9.92-18.23-10.13-0.33-0.02
FCF Margin
-2712.47%-2062.79%-5193.45%-3400.67%--8779.35%
Free Cash Flow Per Share
-0.17-0.14-0.32-0.26-0.07-0.00
Levered Free Cash Flow
-24.12-26.36-45.01-15.670.13-0.71
Unlevered Free Cash Flow
-29.18-28.61-38.63-12.75-0.220.02
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.